MORF: Morphic Holding, Inc. Company Short-Term Debt

Symbol and logo of brand Morphic Holding Inc (MORF)

Morphic Holding, Inc. (MORF) specializes in developing innovative therapies for digestive system pathologies. This chart of share prices demonstrates the price action of an asset whose development is based on the digital modeling of molecular bonds. Meanwhile, Morphic Holding, Inc. (MORF) adheres to environmental standards and bioethics in testing, maintaining the 0.01 metric. Following its merger with Eli Lilly, its research potential scaled, allowing for the optimization of R&D costs.

MORF (Morphic Therapeutic) Company Short-Term Debts history from 07/04/2022 to 08/24/2024

Analytical breakdowns for Morphic Holding, Inc.

- current quotes and average value forecast:
Price Chart Morphic|MORF - Fair Value Consensus
- market capitalization information:
Market Value Morphic Therapeutic|MORF - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Morphic|MORF - Book Capitalization|Market Cap to Net Assets Ratio morphictx.com|MORF - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Morphic Holding, Inc.|MORF - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Morphic Holding, Inc.|MORF - Company Total Debt Obligations|Debt to Book Value Morphic Therapeutic|MORF - Amount of Long-Term Liabilities|Company Short-Term Debt Morphic|Quick Liquidity morphictx.com
- net income and valuation multiples indicators:
MORF - Company Net Income
Fundamental company analysis:Morphic - MORF
Manufactured products of Morphic Holding Corp

This metric aggregates all short-term credit obligations and liabilities of Morphic Holding, Inc. (MORF) due within the coming year. By analyzing the company's current liabilities, an investor assesses the liquidity of this non-cyclical biotech business, where stable demand for gastrointestinal and vascular therapies should ensure debt coverage regardless of market conditions or clinical trial stages.

Who Morphic Holding, Inc. competes with

PHAT - Company Short-Term Debt|Company Short-Term Loans and Borrowings TERN (Terns Pharma)|ironwoodpharma.com (IRWD) - Company Short-Term Debt|Company Current Liabilities Curanex Pharmaceuticals|IMRN (Immuron Ltd) - Company Short-Term Debts|Company Short-Term Debts evokepharma.com|Company Current Liabilities ENTO (Entero Therapeutics, Inc.)|RDHL (redhillbio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts PALI (Palisade Bio)|Short-Term Indebtedness Jaguar Health Corp|Biora Therapeutics - Company Short-Term Debts